Vident Investment Advisory’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-240,128
| Closed | -$16.6M | – | 252 |
|
|
2023
Q2 | $16.6M | Buy |
240,128
+5,963
| +3% | +$424K | 0.57% | 33 |
|
|
2023
Q1 | $17.4M | Buy |
234,165
+44,178
| +23% | +$3.7M | 0.56% | 22 |
|
|
2022
Q4 | $17.7M | Sell |
189,987
-16,772
| -8% | -$1.62M | 0.67% | 22 |
|
|
2022
Q3 | $19.1M | Buy |
206,759
+5,373
| +3% | +$532K | 0.62% | 21 |
|
|
2022
Q2 | $18.7M | Buy |
201,386
+28,007
| +16% | +$2.73M | 0.56% | 33 |
|
|
2022
Q1 | $17.5M | Buy |
173,379
+102,069
| +143% | +$10.7M | 0.46% | 54 |
|
|
2021
Q4 | $7.36M | Sell |
71,310
-14,921
| -17% | -$1.38M | 0.19% | 117 |
|
|
2021
Q3 | $7.32M | Buy |
86,231
+15,328
| +22% | +$1.28M | 0.22% | 83 |
|
|
2021
Q2 | $5.92M | Buy |
70,903
+16,540
| +30% | +$1.35M | 0.18% | 102 |
|
|
2021
Q1 | $4.09M | Buy |
54,363
+7,949
| +17% | +$579K | 0.14% | 131 |
|
|
2020
Q4 | $3.17M | Buy |
46,414
+2,778
| +6% | +$181K | 0.13% | 128 |
|
|
2020
Q3 | $2.55M | Sell |
43,636
-8,446
| -16% | -$526K | 0.13% | 148 |
|
|
2020
Q2 | $3.38M | Sell |
52,082
-1,207
| -2% | -$76K | 0.18% | 98 |
|
|
2020
Q1 | $3.16M | Buy |
53,289
+29,108
| +120% | +$1.94M | 0.21% | 88 |
|
|
2019
Q4 | $1.8M | Sell |
24,181
-310
| -1% | -$21.8K | 0.11% | 281 |
|
|
2019
Q3 | $1.54M | Buy |
24,491
+12,066
| +97% | +$715K | 0.14% | 109 |
|
|
2019
Q2 | $677K | Sell |
12,425
-38,184
| -75% | -$2.06M | 0.05% | 236 |
|
|
2019
Q1 | $2.73M | Sell |
50,609
-8,604
| -15% | -$531K | 0.15% | 176 |
|
|
2018
Q4 | $3.88M | Sell |
59,213
-120
| -0.2% | -$8.96K | 0.22% | 83 |
|
|
2018
Q3 | $4.67M | Buy |
59,333
+1,290
| +2% | +$92.2K | 0.18% | 87 |
|
|
2018
Q2 | $3.73M | Sell |
58,043
-1,196
| -2% | -$78.8K | 0.15% | 143 |
|
|
2018
Q1 | $3.95M | Buy |
59,239
+8,474
| +17% | +$608K | 0.16% | 114 |
|
|
2017
Q4 | $3.68M | Sell |
50,765
-132
| -0.3% | -$9.6K | 0.17% | 113 |
|
|
2017
Q3 | $4.14M | Buy |
50,897
+17,924
| +54% | +$1.42M | 0.22% | 75 |
|
|
2017
Q2 | $2.65M | Buy |
32,973
+568
| +2% | +$44.8K | 0.22% | 135 |
|
|
2017
Q1 | $2.54M | Buy |
+32,405
| New | +$2.59M | 0.25% | 144 |
|
|
2016
Q1 | – | Sell |
-14,774
| Closed | -$1.44M | – | 377 |
|
|
2015
Q4 | $1.44M | Buy |
14,774
+14,729
| +32,731% | +$1.44M | 0.18% | 253 |
|
|
2015
Q3 | $4K | Sell |
45
-241
| -84% | -$25.3K | ﹤0.01% | 889 |
|
|
2015
Q2 | $30K | Buy |
+286
| New | +$29.2K | ﹤0.01% | 865 |
|
|
2015
Q1 | – | Sell |
-14,182
| Closed | -$1.37M | – | 706 |
|
|
2014
Q4 | $1.37M | Buy |
+14,182
| New | +$1.25M | 0.46% | 14 |
|
Other funds holding CVS
Vident Investment Advisory's CVS Position: Q3 2023 in Review
Vident Investment Advisory sold out of CVS Health (CVS) in Q3 2023, closing a stake of 240,128 shares — an estimated $16.6M sold.
Vident Investment Advisory first reported a position in CVS in Q4 2014 and held it in 30 quarters. The position peaked at $19.1M in Q3 2022. 2,113 funds tracked by Wall St. Rank hold CVS as of Q3 2023.
- Vident Investment Advisory reported no remaining CVS Health position as of Q3 2023 after selling out during the quarter.
- Vident Investment Advisory sold 240,128 CVS Health shares in Q3 2023, an estimated $16.6M.
- Vident Investment Advisory first reported a position in CVS Health in Q4 2014 and held it in 30 quarters.
- Vident Investment Advisory's CVS Health position peaked at $19.1M in Q3 2022.
- 2,113 funds tracked by Wall St. Rank held CVS Health as of Q3 2023.
Based on Vident Investment Advisory's 13F filing for Q3 2023.